Ironwood Pharmaceuticals, Inc. (IRWD)
3.82
-0.05
(-1.29%)
USD |
NASDAQ |
Oct 09, 16:00
3.81
-0.01
(-0.26%)
After-Hours: 20:00
Ironwood Pharmaceuticals Total Return Level : 3.82 for Oct. 9, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| October 09, 2026 | 3.82 |
| October 08, 2026 | 3.87 |
| October 07, 2026 | 3.75 |
| October 06, 2026 | 3.63 |
| October 05, 2026 | 3.65 |
| October 02, 2026 | 3.64 |
| October 01, 2026 | 3.76 |
| September 30, 2026 | 3.97 |
| September 29, 2026 | 4.16 |
| September 28, 2026 | 4.12 |
| September 25, 2026 | 4.13 |
| September 24, 2026 | 4.19 |
| September 23, 2026 | 4.27 |
| September 22, 2026 | 4.525 |
| September 21, 2026 | 4.41 |
| September 18, 2026 | 4.36 |
| September 17, 2026 | 4.23 |
| September 16, 2026 | 4.17 |
| September 15, 2026 | 4.06 |
| September 14, 2026 | 4.17 |
| September 11, 2026 | 4.08 |
| September 10, 2026 | 3.97 |
| September 09, 2026 | 4.07 |
| September 08, 2026 | 4.17 |
| September 04, 2026 | 4.26 |
| Date | Value |
|---|---|
| September 03, 2026 | 4.29 |
| September 02, 2026 | 4.41 |
| September 01, 2026 | 4.27 |
| August 31, 2026 | 4.25 |
| August 28, 2026 | 4.13 |
| August 27, 2026 | 4.24 |
| August 26, 2026 | 4.29 |
| August 25, 2026 | 4.39 |
| August 24, 2026 | 4.13 |
| August 21, 2026 | 4.29 |
| August 20, 2026 | 4.14 |
| August 19, 2026 | 4.36 |
| August 18, 2026 | 4.31 |
| August 17, 2026 | 4.36 |
| August 14, 2026 | 4.31 |
| August 13, 2026 | 4.08 |
| August 12, 2026 | 4.32 |
| August 11, 2026 | 4.30 |
| August 10, 2026 | 4.05 |
| August 07, 2026 | 4.32 |
| August 06, 2026 | 4.26 |
| August 05, 2026 | 4.15 |
| August 04, 2026 | 4.31 |
| August 03, 2026 | 4.42 |
| July 31, 2026 | 4.23 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| AbbVie, Inc. | 476.22 |
| Xencor, Inc. | 24.63 |
| Viking Therapeutics, Inc. | 28.51 |
| IDEAYA Biosciences, Inc. | 36.11 |
| BioMarin Pharmaceutical, Inc. | 54.80 |